Regulation, risk and safety of Faecal Microbiota Transplant
Summary: From its origins as a left-field, experimental, and even "maverick" intervention, faecal microbiota transplantation (FMT) is now a well-recognised, accepted, and potentially life-saving therapeutic strategy, for the management of recurrent Clostridiodes difficile infection (rCDI)....
Saved in:
Main Authors: | Blair Merrick (Author), Liz Allen (Author), Nur Masirah M Zain (Author), Ben Forbes (Author), Debbie L. Shawcross (Author), Simon D. Goldenberg (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modulation of the Gut Microbiota to Control Antimicrobial Resistance (AMR)-A Narrative Review with a Focus on Faecal Microbiota Transplantation (FMT)
by: Blair Merrick, et al.
Published: (2023) -
Recurrent <i>Campylobacter jejuni</i> Infection in an Immunodeficient Patient Treated with Repeated Faecal Microbiota Transplant (FMT)-A Case Report
by: Blair Merrick, et al.
Published: (2022) -
Parkinson's Disease and the faecal microbiota transplantation. Review of current knowledge
by: Marcin Dudek, et al.
Published: (2024) -
Patient perception and approval of faecal microbiota transplantation (FMT) as an alternative treatment option for obesity
by: F. Gundling, et al.
Published: (2019) -
Faecal microbiota transplant in a child with very early onset inflammatory bowel disease
by: Carlos Sierra Salinas, et al.
Published: (2018)